Repotrectinib in a Patient With NTRK Fusion-Positive Pancreatic Carcinoma and Congenital Long QT Syndrome.
JCO Precis Oncol
; 8: e2300265, 2024 Jan.
Article
in En
| MEDLINE
| ID: mdl-38271657
ABSTRACT
Repotrectinib in a patient with NTRK fusion-positive pancreatic carcinoma and congenital long QT syndrome.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Long QT Syndrome
/
Macrocyclic Compounds
Type of study:
Diagnostic_studies
Limits:
Humans
Language:
En
Journal:
JCO Precis Oncol
Year:
2024
Document type:
Article
Affiliation country:
Canada
Country of publication:
EEUU
/
ESTADOS UNIDOS
/
ESTADOS UNIDOS DA AMERICA
/
EUA
/
UNITED STATES
/
UNITED STATES OF AMERICA
/
US
/
USA